ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
Titel:
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
Auteur:
Kiladjian, Jean-Jacques Marin, Francisca Ferrer Al-Ali, Haifa Kathrin Alvarez-Larrán, Alberto Beggiato, Eloise Bieniaszewska, Maria Breccia, Massimo Buxhofer-Ausch, Veronika Cerna, Olga Crisan, Ana-Manuela Danaila, Catalin Doru De Stefano, Valerio Döhner, Konstanze Empson, Victoria Gora-Tybor, Joanna Griesshammer, Martin Grosicki, Sebastian Guglielmelli, Paola García-Gutierrez, Valentin Heidel, Florian H. Illés, Arpád Tomuleasa, Ciprian James, Chloe Koschmieder, Steffen Krauth, Maria-Theresa Krejcy, Kurt Lazaroiu, Mihaela-Cornelia Mayer, Jiri Nagy, Zsolt György Nicolini, Franck-Emmanuel Palandri, Francesca Pappa, Vassiliki Reiter, Andreas Johannes Sacha, Tomasz Schlager, Stefanie Schmidt, Stefan Terpos, Evangelos Unger, Martin Wölfler, Albert Cirici, Blanca Xicoy Klade, Christoph